Functional effects of drugs and toxins interacting with NaV1.4

Front Pharmacol. 2024 Apr 25:15:1378315. doi: 10.3389/fphar.2024.1378315. eCollection 2024.

Abstract

NaV1.4 is a voltage-gated sodium channel subtype that is predominantly expressed in skeletal muscle cells. It is essential for producing action potentials and stimulating muscle contraction, and mutations in NaV1.4 can cause various muscle disorders. The discovery of the cryo-EM structure of NaV1.4 in complex with β1 has opened new possibilities for designing drugs and toxins that target NaV1.4. In this review, we summarize the current understanding of channelopathies, the binding sites and functions of chemicals including medicine and toxins that interact with NaV1.4. These substances could be considered novel candidate compounds or tools to develop more potent and selective drugs targeting NaV1.4. Therefore, studying NaV1.4 pharmacology is both theoretically and practically meaningful.

Keywords: Nav1.4; drug design; mexiletine; skeletal muscle; tetrodotoxin; voltage-gated channel.

Publication types

  • Review

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was supported by Zhejiang Provincial Natural Science Foundation of China under Grant No. LY20C040001 to LP and Grant No. LBY22H270002 to WZ; it was also supported by Scientific Research and Development Fund of Zhejiang Shuren University (2023R009) to LP.